Absci (ABSI) Other Operating Expenses (2020 - 2026)
Absci's (ABSI) quarterly Other Operating Expenses came in at $2.7 million in Q1 2026, down 11.2% year-on-year from $3.1 million in Q1 2025, and up 220.02% quarter-over-quarter from -$2.3 million in Q4 2025.
Absci (ABSI) Other Operating Expenses (2020 - 2026) Analysis & Trends
Absci has disclosed Other Operating Expenses across 7 years of filings, most recently posting $2.7 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $2.7 million, down 11.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (down 22.69% YoY), and the FY2025 annual result was -$1.8 million, down 151.9% from the prior year.
- Other Operating Expenses came in at $2.7 million for Q1 2026 at Absci, up from -$2.3 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $22.1 million in Q2 2023 to a low of -$2.3 million in Q4 2025.
- The 5-year median for Other Operating Expenses is $855000.0 (2024), against an average of $2.7 million.
- Across the five-year window, Other Operating Expenses surged 2531.75% in 2023 and plunged 372.54% in 2025, its largest moves.
- Absci's Other Operating Expenses stood at $786000.0 in 2022, then climbed by 12.47% to $884000.0 in 2023, then slipped by 5.66% to $834000.0 in 2024, then slumped by 372.54% to -$2.3 million in 2025, then surged by 220.02% to $2.7 million in 2026.
- The last three Other Operating Expenses figures came in at $2.7 million (Q1 2026), -$2.3 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | -2.27 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 834,000.00 |
| Sep 30, 2024 | 855,000.00 |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 884,000.00 |
| Sep 30, 2023 | 813,000.00 |
| Jun 30, 2023 | 22.13 Mn |
| Mar 31, 2023 | 804,000.00 |
| Dec 31, 2022 | 786,000.00 |
| Sep 30, 2022 | 804,000.00 |
| Jun 30, 2022 | 841,000.00 |
| Mar 31, 2022 | 806,000.00 |
| Dec 31, 2021 | 859,000.00 |
| Sep 30, 2021 | 818,000.00 |
| Jun 30, 2021 | 301,000.00 |